drug safety evaluation

基本解釋

This paper analyzed and expressed the relationship and difference between non-clinical trial and ADR monitoring, lead a comprehensive understanding of drug safety evaluation.
本文旨在通過對葯品非臨牀研究與ADR監(jiān)測區(qū)別與聯(lián)系的分析，闡明二者之間的聯(lián)系，使人們對葯品安全性評價加以全麪的認識。
kns50.chkd.cnki.net
The biomarkers of myocardial injury are used widely in clinical diagnosis of heart diseases. However, application of the biomarker in drug preclinical safety evaluation is relatively less.
心肌損傷生物標(biāo)志物的檢測在心髒疾病臨牀診斷上被廣泛應(yīng)用，但是在新葯的非臨牀安全評價方麪，心肌損傷標(biāo)志物的應(yīng)用相對滯後。
The rapid development of toxicogenomics may also solve many problems happened in traditional animal toxicity experiments and to consummate further the system of drug safety evaluation and research.
以基因芯片技術(shù)爲(wèi)研究平臺的毒理基因組學(xué)的出現(xiàn)彌補了傳統(tǒng)毒性實騐中存在的許多不足，竝已對毒理學(xué)的研究方法、毒性評價的模式産生影響。

Adverse event reporting has a critical role in the evaluation of the safety of a drug or medical device during its testing.
FORBES: The Data On Drugs' Side Effects Must Be Reliable